MATTHEW MCCLUSKEY: Open Payments
NPI 1164161758 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,577 in 91 payments from 19 companies in 2025. Trend: 2023 $165 · 2024 $896 · 2025 $1,577
Food & beverage: $1,577
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $384 |
| AstraZeneca Pharmaceuticals LP | 12 | $309 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $148 |
| Lilly USA, LLC | 5 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| PFIZER INC. | 4 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $66 |
| SHIELD THERAPEUTICS INC | 3 | $57 |
| Novo Nordisk Inc | 3 | $57 |
| GlaxoSmithKline, LLC. | 3 | $55 |
Products named: BREZTRI, VRAYLAR, Kerendia, QULIPTA, FARXIGA, UBRELVY, CAPLYTA, NURTEC ODT.
Industry payments across SC — which companies pay providers there.
